DYNE THERAPEUTICS INC (DYN)
US26818M1080 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -294.51M | -235.94M | -168.10M | -149.29M | -59.44M | |||
| Depreciation Amortization | 1.63M | 1.67M | 1.68M | 1.09M | 700.00K | |||
| Change In Working Capital | 11.12M | 26.31M | -5.38M | 9.26M | 5.11M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 330.00K | |||
| Other non cash items | 38.72M | 19.80M | 18.15M | 19.38M | 7.12M | |||
| OPERATING CASH FLOW | -243.04M | -188.16M | -153.65M | -119.56M | -46.51M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.38M | -729.00K | -3.07M | -3.62M | -1.16M | |||
| Other Investing Activity | -160.49M | 84.04M | 90.27M | -134.27M | -44.50M | |||
| INVESTING CASH FLOW | -161.88M | 83.31M | 87.20M | -137.89M | -45.66M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | -60.00K | |||
| Stock Issued/Repurchased | 806.40M | 54.32M | 37.39M | 157.82M | 381.20M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | -450.00K | |||
| FINANCING CASH FLOW | 806.40M | 54.32M | 37.39M | 157.82M | 380.69M | |||
| CHANGE IN CASH | 401.48M | -50.52M | -29.06M | -99.63M | 288.52M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -243.04M | -188.16M | -153.65M | -119.56M | -46.51M | |||
| Capital Expenditure | -1.38M | -729.00K | -3.07M | -3.62M | -1.16M | |||
| FREE CASH FLOW | -244.42M | -188.89M | -156.72M | -123.18M | -47.67M | |||
All data in USD